Observe Medical ASA Completes Private Placement, Allocations and Shareholdings Update

Strategic Insights -

Observe Medical ASA has completed its private placement of 72,890,000 new shares, raising gross proceeds of NOK 36,445,000. The company's share capital has been increased through the issuance of new shares, including 10,000,000 new shares to Navamedic ASA and 6,000,000 new shares to Jiangsu Hongxin Medical Technology Co. Ltd. The allocations of new shares to primary insiders and close associates have become unconditional. The share capital increase has also led to changes in shareholdings, with Jiangsu, Navamedic ASA, Seed Capital AS, and King Kong Invest AS increasing their holdings and crossing certain ownership thresholds.

Key Takeaways:

  • The private placement of 72,890,000 new shares was completed, raising gross proceeds of NOK 36,445,000 at a subscription price of NOK 0.50 per share.
  • The company's share capital has been increased by the issuance of new shares, including 10,000,000 new shares to Navamedic ASA and 6,000,000 new shares to Jiangsu Hongxin Medical Technology Co. Ltd.
  • Allocations of new shares to primary insiders and close associates have become unconditional.
  • Jiangsu Hongxin Medical Technology Co. Ltd is allocated 6,000,000 shares, representing approximately 6.51% of the issued share capital and voting rights, and has crossed the 5% threshold.
  • Navamedic ASA is allocated 10,000,000 shares and will increase its holding to 13,007,317 shares, representing approximately 14.1% of the issued share capital and voting rights, and has crossed the 10% threshold.
  • Seed Capital AS, a company controlled by Eskild Endrerud, is allocated 5,000,000 shares and will increase its holding to 5,016,155 shares. Eskil Endrerud will, together with his affiliates, hold in total 5,993,140 shares, representing approximately 6.5% of the issued share capital and voting rights.
  • King Kong Invest AS is allocated 6,000,000 shares and will increase its holding to 6,333,333 shares, representing approximately 6.87% of the issued share capital and voting rights, and has crossed the 5% threshold.

Statistics:

  • Number of new shares issued: 72,890,000
  • Gross proceeds: NOK 36,445,000
  • Subscription price per share: NOK 0.50
  • Total issued share capital: NOK 38,702,333.04
  • Total number of shares: 92,148,412
  • Number of shares allocated to Jiangsu Hongxin Medical Technology Co. Ltd: 6,000,000
  • Number of shares allocated to Navamedic ASA: 10,000,000
  • Number of shares allocated to Seed Capital AS: 5,000,000
  • Number of shares allocated to King Kong Invest AS: 6,000,000

Sources:

  • Observe Medical ASA (11 June 2025)
  • Observe Medical ASA (1 July 2025)